- Home
- » Tags
- » Dopamine agonist
Top View
- 5-HT Receptors Review
- Prolactin and Fmri Response to SKF38393 in the Baboon Brad Miller1, Lauren A
- Dopamine Agonists Diminish Value Sensitivity of the Orbitofrontal Cortex: a Trigger for Pathological Gambling in Parkinson’S Disease?
- NMDA-Sensitive Glutamate Antagonism: a Human Model for Psychosis Adrienne C
- Levodopa Non-Ergot Dopamine Agonist Monoamine Oxidase Type
- Pharmacological Treatments for Tinnitus
- PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors
- Dopamine Partial Agonist Reverses Amphetamine Withdrawal in Rats Cristina Orsini, Ph.D., George F
- Official Title: a Randomized, Double-Blind, Placebo-Controlled, 52-Week Phase II Study to Evaluate the Efficacy of Intravenous R
- Effects of Risperidone on Phencyclidine-Induced Behaviors: Comparison with Haloperidol and Ritanserin
- Selegiline Enhances Erectile Activity Induced by Dopamine Injection in the Paraventricular Nucleus of the Hypothalamus in Anesthetized Rats
- Rapid Development of Dopaminergic Supersensitivity in Reserpine- Treated Rats Demonstrated with 14C-2-Deoxyglucose Autoradiography
- Current Concepts and Treatments of Schizophrenia
- Psychoactive Plant Species – Actual List of Plants Prohibited in Poland
- Utah Medicaid Pharmacy & Therapeutics Committee Drug
- In Silico Studies Targeting G-Protein Coupled Receptors for Drug Research Against Parkinson’S Disease
- Quick Reference to Psychotropic Medication® Developed by John Preston, Psy.D
- Neuropsychiatric and Metabolic Aspects of Dopaminergic Therapy: Perspectives from an Endocrinologist and a Psychiatrist
- Chronic Treatment with Dopamine Receptor Antagonists: Behavioral and Pharmacologic Effects on D, and D, Dopamine Receptors
- Developmental Neurotoxicity of Ketamine in Pediatric Clinical Use
- Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
- Dissociable Antidepressant-Like and Abuse-Related Effects of the Noncompetitive NMDA Receptor Antagonists Ketamine and MK-801 in Rats
- Novel Insights in Dopamine Receptor Physiology
- Echoclubdrugs
- Effects of Cariprazine, a Novel Antipsychotic, on Cognitive Deficit
- From Local to Global—Fifty Years of Research on Salvia Divinorum
- Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: from Mechanistic Advances to More Personalized Treatments
- Serotonin and Parkinson's Disease
- Musa Paradisiaca Using Various Experimental Models
- Real-World Pharmacological Treatment Patterns of Patients with Young
- Moreira and Cordeiro-MS
- Understanding Parkinson's
- Pass Assured's Pharmacy Technician Training Program
- Pharmacokinetics and Pharmacodynamics of Salvinorin a and Salvia Divinorum: Clinical and Forensic Aspects
- The Antiparkinsonian Actions and Pharmacokinetics of Transdermal (+
- Dopaminergic Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder
- Dopamine Agonists, MAO-B Inhibitors, and More
- Treatment of Bipolar Disorders Chapter 14. Mood
- New Therapeutic Opportunities for 5-HT2 Receptor Ligands
- Maximizing PD Medications: How to Get the Most out of Your Treatment Plan
- Effects of Ketamine in Normal and Schizophrenic Volunteers Adrienne C
- Relevance of the Kappa Dynorphin System to Schizophrenia and Its Therapeutics
- The Delayed Effects of DTG and MK-801 on Latent Inhibition in a Conditioned Taste-Aversion Paradigm
- Botanical Influences on Neurotransmitters Part I -NEURO PHYSIOLOGY BASICS
- Long-Term Persistence of Withdrawal of Temazepam, Zopiclone, and Zolpidem in Older Adults: a 3-Year Follow-Up Study
- Serotonin-And-Parkinson.Pdf
- (2R,6R)-Hydroxynorketamine Exerts Mglu2 Receptor- Dependent Antidepressant Actions